Cargando…

Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings

INTRODUCTION: Direct oral anticoagulants (DOACs) have emerged as viable alternatives to traditional treatments such as vitamin K antagonists (VKAs) for venous thromboembolism (VTE). The objective of this review was to summarize evidence on the use of DOACs and VKAs to treat VTE in the US for patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trocio, Jeffrey, Rosen, Virginia M, Gupta, Anu, Dina, Oluwaseyi, Vo, Lien, Hlavacek, Patrick, Rosenblatt, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305128/ https://www.ncbi.nlm.nih.gov/pubmed/30588051 http://dx.doi.org/10.2147/CEOR.S179080

Ejemplares similares

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population
por: Amin, Alpesh, et al.
Publicado: (2018)

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population
por: Amin, Alpesh, et al.
Publicado: (2020)

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
por: Cohen, Alexander, et al.
Publicado: (2021)

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2018)

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States
por: Amin, Alpesh, et al.
Publicado: (2015)

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
por: Cohen, Alexander T., et al.
Publicado: (2021)

Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population
por: Gupta, Kiran, et al.
Publicado: (2018)

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
por: Cohen, Alexander T., et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status
por: Cohen, Alexander T., et al.
Publicado: (2021)

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis
por: Cohen, Alexander, et al.
Publicado: (2021)

Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database
por: Guo, Jennifer D., et al.
Publicado: (2020)

Incidence of venous thromboembolism in psychiatric inpatients: a chart review
por: Takeshima, Masahiro, et al.
Publicado: (2018)

Venous thromboembolism (VTE) risk assessment completion in psychiatric inpatients
por: Powell, Harriet, et al.
Publicado: (2021)

Incidence and Clinical Features of Venous Thromboembolism in Inpatients with Mental Illness
por: Wang, Zibin, et al.
Publicado: (2023)

Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population
por: Gupta, Kiran, et al.
Publicado: (2019)

Audit on venous thromboembolism risk assessment in mental health inpatient wards
por: Malhotra, Rahul
Publicado: (2021)

Thirty-day readmissions due to Venous thromboembolism in patients discharged with syncope
por: Siddappa Malleshappa, Sudeep K., et al.
Publicado: (2020)

Prediction of venous thromboembolism with machine learning techniques in young-middle-aged inpatients
por: Liu, Hua, et al.
Publicado: (2021)

SAT513 Venous Thromboembolism and Thyroid Cancer. Analysis of National Inpatient Sample
por: Botros, Mina, et al.
Publicado: (2023)

Transitions in the Prophylaxis, Treatment and Care of Patients with Venous Thromboembolism
por: Lenchus, Joshua D.
Publicado: (2015)

Risk assessment and prophylaxis of venous thromboembolism in surgical inpatients: improving adherence to national guidelines
por: Johnson, Oscar, et al.
Publicado: (2015)

The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism: Outpatient versus inpatient management
por: Al-Hameed, Fahad M., et al.
Publicado: (2015)

Venous Thromboembolism in Hospitalized Melanoma Patients: Analysis from the National Inpatient Sample Database
por: Alhasson, Hussam, et al.
Publicado: (2021)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
por: MacLehose, Richard F., et al.
Publicado: (2021)

Risk Factor Analysis of Venous Thromboembolism in Cancer: A National Inpatient Sample Study
por: Rijal, Satya, et al.
Publicado: (2022)

A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19
por: Amani-Beni, Reza, et al.
Publicado: (2023)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Venous Thromboembolism and Thymic Hyperplasia in the Setting of Silent Graves' Disease
por: Rayan, Melanie N, et al.
Publicado: (2022)

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
por: Liang, Huifang, et al.
Publicado: (2019)

Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
por: Katiyar, Vatsala, et al.
Publicado: (2019)

Current Opinion on the use of Direct Oral Anticoagulants for the Prophylaxis of Venous Thromboembolism among Medical Inpatients
por: Lee, Jane J, et al.
Publicado: (2021)

Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients
por: Davila, Jennifer, et al.
Publicado: (2022)

Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients
por: Lammers, Daniel, et al.
Publicado: (2023)

Prevention of Venous Thromboembolism in 2020 and Beyond
por: Nicholson, Matthew, et al.
Publicado: (2020)

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
por: Cohen, Alexander T., et al.
Publicado: (2023)

Development of a computable phenotype using electronic health records for venous thromboembolism in medical inpatients: the Medical Inpatient Thrombosis and Hemostasis study
por: Thomas, Ryan M., et al.
Publicado: (2023)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Venous thromboembolism and pregnancy
por: D’Uva, Maristella, et al.
Publicado: (2010)

The epidemiology of venous thromboembolism
por: Heit, John A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_70lk9mnubrs35lcbhncg7c6ie2